Skip to main content

Table 1 Characteristics of the gout patients who responded to the questionnaire

From: Patients’ knowledge and beliefs concerning gout and its treatment: a population based study

Demographics Total N = 240 Active gout N = 53 Inactive gout N = 187 P value
Age (N and%)     0.016
<65 81 (34) 12 (23) 69 (37)  
65-74 93 (39) 17 (32) 76 (41)  
75 or older 66 (28) 24 (45) 42 (22)  
Gender (% male) 193 (80) 37 (70) 156 (83) 0.028
Race (N and%)     0.825
Caucasian 225 (94) 50 (94) 175 (94)  
Native American 9 (4) 2 (4) 7 (4)  
Hispanic 3 (1) 1 (2) 2 (1)  
Black 2 (1) 0 (0) 2 (1)  
Asian 1 (0) 0 (0) 1 (1)  
Highest grade completed (N and%)     0.331
No high school degree 33 (14) 9 (18) 24 (13)  
High school graduate 86 (36) 19 (37) 67 (36)  
College 118 (50) 23 (45) 95 (51)  
Health Behaviors     
Current smoking (N and%) 13 (5) 3 (6) 10 (5) 0.929
Alcohol use* (N and%) 94 (39) 13 (25) 81 (43) 0.014
Associated Conditions     
Dyslipidemia (N and%) 196 (82) 45 (85) 151 (82) 0.581
Hypertension (N and%) 185 (78) 44 (83) 141 (76) 0.295
Diabetes mellitus (N and%) 91 (38) 22 (42) 69 (37) 0.579
Coronary heart disease (N and%) 77 (32) 21 (40) 56 (30) 0.200
Renal disease (N and%) 43 (18) 12 (23) 31 (17) 0.327
Peripheral arterial disease (N and%) 21 (9) 8 (15) 13 (7) 0.069
Nephrolithiasis (N and%) 17 (7) 4 (8) 13 (7) 0.897
Gout history     
Gout encounters (mean, ± SD)** 1 (2) 2 (3) 1 (2)  
Cared for by a rheumatologist (N and%) 14 (6) 8 (19) 6 (4)  
ULD dispensing (N and%) ** 108 (47) 37 (70) 77 (42) 0.0004
Colchicine use (N and%)** 59 (26) 23 (43) 37 (21) 0.0011
Glucocorticoid use (N and%)** 44 (19) 19 (36) 26 (14) 0.0005
NSAID use (N and%)** 72 (32) 14 (26) 60 (33) 0.355
  1. * reports having 2 or more drinks of alcohol in the last 7 days.
  2. ** based on visits or dispensing of urate-lowering drugs (ULDs), colchicine, steroids and NSAIDs in the prior 12 months.